Biotech

All Articles

A better look at Strong Biotech's Fierce 15

.In this full week's episode of "The Leading Pipe," we're diving right into Strong Biotech's annual ...

Lilly experiences phase 2 failing of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's celebration commemorating the approval of A...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable management hirings, shootings...

Lykos will talk to FDA to reassess its choice following turndown of MDMA treatment for trauma

.Observing a bad presenting for Lykos Therapeutics' MDMA candidate for post-traumatic stress disorde...

AN 2 fifty percents census, ceases period 3 test after information let down

.AN2 Therapies is actually reassessing its own company in response to poor midphase records, swearin...

Merck pays out $700M for bispecific, snooping autoimmune position as well as odds to challenge Amgen in cancer cells

.Merck &amp Co. is paying out $700 thousand in advance to challenge Amgen in a blood stream cancer m...

Gilead spends J&ampJ $320M to exit licensing package for seladelpar

.Along With Gilead Sciences almost an FDA selection for its liver ailment medicine seladelpar, the b...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks may see the firms setting up camping tents at basecamp behind Eli Lilly in an effor...

Entero laying off workers, leaving workplace and stopping briefly R&ampD

.Bed Liquidators has actually turned Entero Therapeutics white as a slab. The collector bought Enter...

Exelixis loses ADC after determining it is actually no match for Tivdak

.Exelixis is actually losing hope on its own cells factor (TF)- targeting antibody-drug conjugate af...